Login to Your Account

Financings Roundup

Aerovance Advancing Clinical Candidates With $28M Tranche

By Jennifer Boggs

Monday, May 8, 2006
The Berkeley, Calif.-based company has received $28 million to advance its two lead molecules in four indications. The remaining funds will become available at a later date. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription